系统综述与荟萃分析:幽门螺杆菌CagA血清阳性与炎症性肠病 odds 的关联
该系统综述与荟萃分析纳入3项临床研究,评估CagA血清阳性与炎症性肠病(IBD)风险的关系。结果显示,CagA血清阳性与较低的IBD(OR 0.31,95%CI 0.21-0.44)和克罗恩病(OR 0.25,95%CI 0.17-0.38)风险相关,但与溃疡性结肠炎风险无显著关联。
要点
- CagA血清阳性与IBD风险降低相关(OR 0.31)。
- CagA血清阳性与克罗恩病风险降低相关(OR 0.25)。
- CagA血清阳性与溃疡性结肠炎风险无显著关联。
核心结论
- CagA血清阳性幽门螺杆菌暴露与IBD风险降低显著相关,尤其是克罗恩病,但CagA血清阴性幽门螺杆菌暴露无此关联。
- 需要更多研究来证实这些发现并明确潜在机制。
研究设计与样本
- 系统综述与荟萃分析,纳入3项符合入选标准的临床比较研究。
- 通过随机效应模型合并效应量。
主要发现
- 与CagA血清阴性总体相比,CagA血清阳性与较低的IBD风险相关(OR 0.31,95%CI 0.21-0.44)和较低的克罗恩病风险相关(OR 0.25,95%CI 0.17-0.38),溃疡性结肠炎风险降低未达统计学显著(OR 0.68,95%CI 0.35-1.32)。
- 与幽门螺杆菌未暴露个体相比,幽门螺杆菌暴露且CagA血清阳性个体的IBD风险较低(OR 0.26,95%CI 0.16-0.41)和克罗恩病风险较低(OR 0.23,95%CI 0.15-0.35),但溃疡性结肠炎风险无显著差异(OR 0.66,95%CI 0.34-1.27)。
- 幽门螺杆菌暴露且CagA血清阴性个体与幽门螺杆菌未暴露个体相比,IBD、克罗恩病或溃疡性结肠炎风险均无显著差异。
关键数值与推荐
- CagA血清阳性 vs CagA血清阴性:IBD的OR 0.31(95%CI 0.21-0.44),克罗恩病的OR 0.25(95%CI 0.17-0.38),溃疡性结肠炎的OR 0.68(95%CI 0.35-1.32)。
- 幽门螺杆菌暴露且CagA血清阳性 vs 幽门螺杆菌未暴露:IBD的OR 0.26(95%CI 0.16-0.41),克罗恩病的OR 0.23(95%CI 0.15-0.35),溃疡性结肠炎的OR 0.66(95%CI 0.34-1.27)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要更多研究来证实这些发现并明确潜在机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accumulating data support a protective role of Helicobacter pylori against inflammatory bowel diseases (IBD), which might be mediated by strain-specific constituents, specifically cagA expression. AIM: To perform a systematic review and meta-analysis to more clearly define the association between CagA seropositivity and IBD. METHODS: We identified comparative studies that included sufficient detail to determine the odds or risk of IBD, Crohn's disease (CD) or ulcerative colitis (UC) amongst individuals with vs without evidence of cagA expression (eg CagA seropositivity). Estimates were pooled using a random effects model. RESULTS: Three clinical studies met inclusion criteria. cagA expression was represented by CagA seropositivity in all studies. Compared to CagA seronegativity overall, CagA seropositivity was associated with lower odds of IBD (OR 0.31, 95% CI 0.21-0.44) and CD (OR 0.25, 95% CI 0.17-0.38), and statistically nonsignificant lower odds for UC (OR 0.68, 95% CI 0.35-1.32). Similarly, compared to H pylori non-exposed individuals, H pylori exposed, CagA seropositive individuals had lower odds of IBD (OR 0.26, 95% CI 0.16-0.41) and CD (OR 0.23, 95% CI 0.15-0.35), but not UC (OR 0.66, 0.34-1.27). However, there was no significant difference in the odds of IBD, CD or UC between H pylori exposed, CagA seronegative and H pylori non-exposed individuals. CONCLUSION: We found evidence for a significant association between CagA seropositive H pylori exposure and reduced odds of IBD, particularly CD, but not for CagA seronegative H pylori exposure. Additional studies are needed to confirm these findings and define underlying mechanisms.
引用
- Tepler A, Narula N, Peek RM, et al. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease. Aliment Pharmacol Ther. 2019. PMID: 31165513. doi:10.1111/apt.15306
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。